Michael Boas
Psychiatric/Mental Health · Ft Lauderdale, FLNPI 1487293296
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,420 and has fallen 97.8% since, to $54 in 2023.
Across 216 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$771
- AbbVie$766
- Alkermes, Inc.$621
- Johnson & Johnson$354
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$324
- Vanda Pharmaceuticals Inc.$276
- plus $831 from 6 others
What the payments were for
- Food & beverage$3,938100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 54 | $771 |
| AbbVie | 41 | $766 |
| Alkermes, Inc. | 25 | $621 |
| Johnson & Johnson | 19 | $354 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $324 |
| Vanda Pharmaceuticals Inc. | 15 | $276 |
| Otsuka America Pharmaceutical, Inc. | 18 | $274 |
| Sunovion Pharmaceuticals Inc. | 17 | $257 |
| Neurocrine Biosciences, Inc. | 8 | $135 |
| Lundbeck LLC | 4 | $102 |
| Almatica Pharma LLC | 3 | $51 |
| Indivior Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$474
- ARISTADA INITIO$119
- CAPLYTA$101
How this compares
$3,943 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine Sulfate ErDextroamphetamine Sulfate | 12 | $4,359 |
| Lisdexamfetamine Dimesylate | 12 | $3,634 |
| Alprazolam | 22 | $147 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $41 |
| Lorazepam | 13 | $0 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Ft Lauderdale
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
- Carolann BrooksCelebration$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.